Prestige BioPharma Limited (KRX:950210)
6,370.00
-130.00 (-2.00%)
Last updated: Sep 1, 2026, 2:31 PM KST
-53.50% (1Y)
| Market Cap | 78.13B -52.6% |
| Revenue (ttm) | 16.21B +87.1% |
| Net Income | -57.32B |
| EPS | -953.45 |
| Shares Out | 12.02M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 27,365 |
| Open | 6,390.00 |
| Previous Close | 6,500.00 |
| Day's Range | 6,240.00 - 6,550.00 |
| 52-Week Range | 4,945.00 - 15,350.00 |
| Beta | 0.36 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 18, 2026 |